Program Timeline Standard dosing requires 500 mcg administered subcutaneously once daily
AOD 9604 With Retatrutide: Evidence, Safety, and UK Regulatory Status AOD 9604 with retatrutide is a combination increasingly discussed in weight-loss and body-composition circles, yet neither compound holds a Marketing Authorisation from the MHRA or EMA for use in the UK
After years of caring for patients in high-stress, fast-paced environments, Tracy developed a deeper passion for wellness, prevention, and helping individuals feel their best long before health concerns become overwhelming
All treatments are administered by licensed clinicians who prioritize comfort, safety and individualized care
Once reconstituted, AHK-Cu must be refrigerated immediately at 28C